Protein Abundance of Clinically Relevant Drug Transporters in The Human Kidneys.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
24 Oct 2019
Historique:
received: 29 09 2019
revised: 21 10 2019
accepted: 22 10 2019
entrez: 27 10 2019
pubmed: 28 10 2019
medline: 7 3 2020
Statut: epublish

Résumé

Renal drug transporters such as the organic cation transporters (OCTs), organic anion transporters (OATs) and multidrug resistance proteins (MRPs) play an important role in the tubular secretion of many drugs influencing their efficacy and safety. However, only little is known about the distinct protein abundance of these transporters in human kidneys, and about the impact of age and gender as potential factors of inter-subject variability in their expression and function. The aim of this study was to determine the protein abundance of MDR1, MRP1-4, BCRP, OAT1-3, OCT2-3, MATE1, PEPT1/2, and ORCTL2 by liquid chromatography-tandem mass spectrometry-based targeted proteomics in a set of 36 human cortex kidney samples (20 males, 16 females; median age 53 and 55 years, respectively). OAT1 and 3, OCT2 and ORCTL2 were found to be most abundant renal SLC transporters while MDR1, MRP1 and MRP4 were the dominating ABC transporters. Only the expression levels of MDR1 and ORCTL2 were significantly higher abundant in older donors. Moreover, we found several significant correlations between different transporters, which may indicate their functional interplay in renal vectorial transport processes. Our data may contribute to a better understanding of the molecular processes determining renal excretion of drugs.

Identifiants

pubmed: 31653114
pii: ijms20215303
doi: 10.3390/ijms20215303
pmc: PMC6862022
pii:
doi:

Substances chimiques

ATP Binding Cassette Transporter, Subfamily G, Member 2 0
Organic Anion Transport Protein 1 0
Organic Cation Transport Proteins 0
Organic Cation Transporter 2 0
Proteome 0
SLC22A18 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : 107/11-1

Références

Curr Opin Nephrol Hypertens. 2013 Sep;22(5):533-8
pubmed: 23852330
J Clin Pharmacol. 2016 Jul;56 Suppl 7:S205-21
pubmed: 27385176
FEBS Lett. 1998 Aug 21;433(3):245-50
pubmed: 9744804
Clin Pharmacol Ther. 2019 Nov;106(5):1083-1092
pubmed: 31127606
Semin Nephrol. 2006 Sep;26(5):386-92
pubmed: 17071332
Nephron Physiol. 2006;103(3):p97-106
pubmed: 16554667
Drug Metab Dispos. 2016 Dec;44(12):1920-1924
pubmed: 27621205
J Am Soc Nephrol. 2002 Mar;13(3):595-603
pubmed: 11856762
J Am Soc Nephrol. 2002 Apr;13(4):866-74
pubmed: 11912245
Acta Pharm Sin B. 2015 Mar;5(2):106-12
pubmed: 26579435
Chembiochem. 2019 May 15;20(10):1210-1224
pubmed: 30609196
APMIS. 1997 Jan;105(1):31-4
pubmed: 9063498
J Am Soc Nephrol. 1999 Jun;10(6):1159-69
pubmed: 10361853
Pediatr Nephrol. 2015 Dec;30(12):2085-98
pubmed: 24253590
Drug Metab Dispos. 2019 Aug;47(8):802-808
pubmed: 31123036
Physiol Rev. 2004 Jul;84(3):987-1049
pubmed: 15269342
Am J Physiol Regul Integr Comp Physiol. 2010 Apr;298(4):R851-61
pubmed: 20106993
Lab Invest. 2002 Feb;82(2):193-201
pubmed: 11850532
AAPS J. 2019 Jul 11;21(5):88
pubmed: 31297641
Tohoku J Exp Med. 1991 Jul;164(3):191-201
pubmed: 1684451
Am J Physiol Renal Physiol. 2016 Jul 1;311(1):F227-38
pubmed: 27053689
Br J Pharmacol. 2011 Jun;163(3):546-55
pubmed: 20883471
Mol Pharm. 2019 Feb 4;16(2):510-517
pubmed: 30656943
J Pharm Biomed Anal. 2013 Nov;85:253-61
pubmed: 23973632
Curr Drug Targets. 2011 May;12(5):600-20
pubmed: 21039335
Biol Sex Differ. 2015 Mar 02;6:4
pubmed: 25750709
Drug Metab Dispos. 2004 Jun;32(6):620-5
pubmed: 15155553
Essays Biochem. 2011 Sep 7;50(1):179-207
pubmed: 21967058
Pflugers Arch. 2007 Dec;455(3):397-429
pubmed: 17638010
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Am J Physiol Cell Physiol. 2006 Jun;290(6):C1521-31
pubmed: 16394027
Kidney Int. 2008 Jan;73(2):220-5
pubmed: 17978814
Physiol Rev. 2019 Jul 1;99(3):1575-1653
pubmed: 31215303
Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):17923-8
pubmed: 16330770
Clin J Am Soc Nephrol. 2015 Nov 6;10(11):2039-49
pubmed: 26490509
Annu Rev Pharmacol Toxicol. 2013;53:503-29
pubmed: 23140242
Am J Physiol Renal Physiol. 2007 Jan;292(1):F361-72
pubmed: 16885152

Auteurs

Stefan Oswald (S)

Department of Clinical Pharmacology, University Medicine of Greifswald, Greifswald, Germany. stefan.oswald@uni-greifswald.de.

Janett Müller (J)

Department of Clinical Pharmacology, University Medicine of Greifswald, Greifswald, Germany. nettie.m@web.de.

Ute Neugebauer (U)

Medicine Clinic D, Experimental Nephrology, University Hospital of Münster, Münster, Germany. Ute.Neugebauer@uni-muenster.de.

Rita Schröter (R)

Medicine Clinic D, Experimental Nephrology, University Hospital of Münster, Münster, Germany. ritas@uni-muenster.de.

Edwin Herrmann (E)

Urology Clinic, University Hospital of Münster, Münster, Germany. edwin.herrmann@prosper-hospital.de.

Hermann Pavenstädt (H)

Medicine Clinic D, Experimental Nephrology, University Hospital of Münster, Münster, Germany. Hermann.Pavenstaedt@ukmuenster.de.

Giuliano Ciarimboli (G)

Medicine Clinic D, Experimental Nephrology, University Hospital of Münster, Münster, Germany. gciari@uni-muenster.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH